Associated Press - May 4, 2001
BRASILIA -- President Fernando Henrique Cardoso on Thursday defended Brazil's policy of ignoring medical patents to guarantee public health, intensifying a dispute with the U.S. over patent rights.
|
"We're not here to challenge and break patents at any price," Globo Online agency quoted the president as saying at the inauguration of a bridge 220 miles south of Brasilia, the nation's capital. "But I want to affirm that if it is for the health of our people, we won't hesitate [to break patents]."
The statement comes after the Bush administration released a report on patent protections that put Brazil and several other countries on notice that they could face U.S. trade sanctions unless they remove objectionable trade barriers to U.S. products.
The U.S. government and many pharmaceutical companies object to announcements by Brazil's government that it may produce generic copies of AIDS drugs in cases where the government finds prices to be excessive.
The U.S. has criticized parts of Brazil's patent law that call for a compulsory licensing of patents in the case of "economic abuse of patent rights." On Feb. 1, the U.S. asked the World Trade Organization to form a panel to check whether Brazil's patent law discriminates against drug imports in violation of the rights of drug companies.
"Brazil will not budge one millimeter in everything that is of interest of our country and our people," Mr. Cardoso said.
Paulo Teixeira, who heads Brazil's anti-AIDS program, said Wednesday his government was "very surprised" that Mr. Bush has toughened the U.S. position on Brazil's policy of producing cheap generic drugs.
Brazil so far has only made copies of AIDS drugs not protected by patents in Brazil. The government has for more than four years provided an AIDS cocktail free to anyone who needs it.
The Brazilian program -- praised by doctors as a model for developing countries -- has reduced AIDS deaths by 50% to 70%, Mr. Teixera said.
010504
AP010541
Copyright © 2001 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
ÆGIS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. ÆGIS. All materials appearing on ÆGIS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS, or the party credited as the provider of the content. Feedback/Contact Us.